04.12.14: Not intended for U.S. and UK Media

Bayer Submits Marketing Authorization Application in Europe for Recombinant Factor VIII Product (BAY 81-8973) for the Treatment of Hemophilia A in Adults and Childrenmehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news